Cargando…
Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells
Murine dendritic cells (DC) transduced to express the Type-1 transactivator T-bet (i.e. mDC.Tbet) and delivered intratumorally (i.t.) as a therapy are superior to control wild-type DC in slowing the growth of established subcutaneous (s.c.) MCA205 sarcomas in vivo. Optimal anti-tumor efficacy of mDC...
Autores principales: | Chen, Lu, Taylor, Jennifer L., Sabins, Nina Chi, Lowe, Devin B., Qu, Yanyan, You, Zhaoyang, Storkus, Walter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775601/ https://www.ncbi.nlm.nih.gov/pubmed/23846252 http://dx.doi.org/10.1038/cgt.2013.42 |
Ejemplares similares
-
Therapeutic effectiveness of intratumorally-delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32
por: Qu, Yanyan, et al.
Publicado: (2011) -
Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
por: Chen, Lu, et al.
Publicado: (2013) -
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2018) -
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2019) -
IFNγ inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms
por: Yeh, Wen-I, et al.
Publicado: (2013)